Idexx Laboratories (IDXX) risk factors, FY2025 10-K

Idexx Laboratories's FY2025 10-K, filed Feb 20, 2026, lists 24 risk factors in 3 groups. Against the prior year's 24: 8 substantially reworded.

Open IDXX in Gloom →
Idexx Laboratories' chart, financials and news, free in your browser.Open IDXX in Gloom →
Risk factors listed
243 groups
New this year
0vs 24 last year
Dropped
0since the prior 10-K
Substantially reworded
8of those kept
Section length
13k wordsItem 1A

What the changes say

  • AI use now extends internally to coding, product development, operational efficiency, innovation, and customer value.
  • IT risk now explicitly covers cloud-based IoT systems, including IDEXX VetLab Stations and analyzers.
  • Talent risk specifically highlights intense competition for software and AI specialists.
  • Tax disclosure adds corporate-structure and intercompany-planning considerations to international tax risk.

What changed since the prior 10-K

Reworded

  • 67% rewrittenRISKS RELATED TO OUR BUSINESS AND INDUSTRY

    Issues in our use of AI may result in reputational harm or liability and adversely affect our business

    Adds internal AI use for code, product development, efficiency, innovation, and customer value, while retaining algorithm and dataset risks.

    Was: Issues in the use of AI in our product offerings may result in reputational harm or liability

  • 51% rewrittenGENERAL RISKS

    We depend on the continuous and reliable operation and security of our information technology systems and our products and services that incorporate or rely on information technology, and any disruption or significant cybersecurity breach or other incident could adversely affect our business

    Expands coverage to cloud-based IoT products, including IDEXX VetLab Stations and analyzers, alongside third-party cloud dependence.

  • 44% rewrittenGENERAL RISKS

    We depend on the efforts of key personnel and talent to succeed and compete effectively

    Specifically identifies software and AI skills as competitive talent areas, while dropping explicit references to geographic expansion and succession planning.

  • 44% rewrittenGENERAL RISKS

    Our operations and reputation may be impaired if we, our products, or our services do not comply with our global privacy policy or evolving laws, regulations, and industry standards regarding data privacy and protection

    Adds transmission to covered data and highlights point-of-sale credit-card processing functionality in veterinary software products.

    Was: Our operations and reputation may be impaired if we, our products, or our services do not comply with our global privacy policy or evolving laws and regulations regarding data privacy and protection

  • 39% rewrittenGENERAL RISKS

    Failure to meet current or evolving environmental, social, and governance regulations, standards, or expectations or to achieve our environmental, social, or governance goals could adversely affect our business, results of operations, financial condition, reputation, or stock price

    Changes stakeholder focus from increasingly focused to focused and removes employees from the listed groups with additional expectations.

  • 33% rewrittenRISKS RELATED TO OUR BUSINESS AND INDUSTRY

    Our business lines are highly attractive and highly competitive. Our failure to successfully execute certain strategies in this competitive environment could have a material negative impact on our future growth and profitability

    Recasts laboratory applications as point-of-care and changes competition from anticipated increasing levels to increasing competition.

    Was: Because our business lines are highly attractive, they are also highly competitive. Our failure to successfully execute certain strategies within this competitive environment could have a material negative impact on our future growth and profitability

  • 31% rewrittenGENERAL RISKS

    Future operating results could be negatively affected by changes in tax rates, the adoption of new tax legislation or exposure to additional tax liabilities

    Adds corporate-structure and intercompany-planning actions for international growth and tax efficiency; the shown text no longer details the 15% Pillar Two minimum.

  • 29% rewrittenRISKS RELATED TO OUR BUSINESS AND INDUSTRY

    Consolidation in our customer base, including through increased corporate hospital ownership, and prevalence of buying consortiums could negatively affect our business

    Adds the United Kingdom and U.S. buying consortiums, while removing references to dozens of consolidators and hospital acquisition or expansion activity.

All 24 risk factors

Headings as the filing states them, in filing order.

RISKS RELATED TO OUR BUSINESS AND INDUSTRY

  1. 01Our business lines are highly attractive and highly competitive. Our failure to successfully execute certain strategies in this competitive environment could have a material negative impact on our future growth and profitability33% rewritten
  2. 02Our dependence on third-party suppliers could negatively affect our ability to sell certain products or deliver our cloud-based software solutions, which could negatively affect our operating results
  3. 03Our biologic products are complex and difficult to manufacture, which could negatively affect our ability to supply our customers
  4. 04Issues in our use of AI may result in reputational harm or liability and adversely affect our business67% rewritten
  5. 05Various U.S. and foreign government regulations could limit or delay our ability to market and sell our products or otherwise negatively impact our business
  6. 06Our success is heavily dependent on our continued differentiated product and service innovation
  7. 07Increased competition from and technological advances by our competitors could negatively affect our operating results
  8. 08Consolidation in our customer base, including through increased corporate hospital ownership, and prevalence of buying consortiums could negatively affect our business29% rewritten
  9. 09Changes in testing patterns could negatively affect our operating results
  10. 10We sell many products through distributors, which presents risks that could negatively affect our operating results

GENERAL RISKS

  1. 11We depend on the efforts of key personnel and talent to succeed and compete effectively44% rewritten
  2. 12We depend on the continuous and reliable operation and security of our information technology systems and our products and services that incorporate or rely on information technology, and any disruption or significant cybersecurity breach or other incident could adversely affect our business51% rewritten
  3. 13Factors and events beyond our control could disrupt our operations, supply chain, and logistics network and adversely affect our business
  4. 14Since our business is global in nature, geopolitical risks and other risks associated with doing business internationally could negatively affect our business, financial condition, and operating results
  5. 15A weak worldwide economy, or actual or perceived economic weakness in any significant geography, could result in reduced demand for our products and services or increased customer credit risk
  6. 16We are subject to risks associated with public health issues, including pandemics, which could have a material adverse effect on our financial condition and results of operations
  7. 17Our operations and reputation may be impaired if we, our products, or our services do not comply with our global privacy policy or evolving laws, regulations, and industry standards regarding data privacy and protection44% rewritten
  8. 18Failure to meet current or evolving environmental, social, and governance regulations, standards, or expectations or to achieve our environmental, social, or governance goals could adversely affect our business, results of operations, financial condition, reputation, or stock price39% rewritten
  9. 19Climate change, or legal, regulatory or market measures to address climate change, could adversely affect our business, financial condition, and results of operation
  10. 20Future operating results could be negatively affected by changes in tax rates, the adoption of new tax legislation or exposure to additional tax liabilities31% rewritten
  11. 21Strengthening of the rate of exchange for the U.S. dollar has a negative effect on our business
  12. 22Restrictions in our debt agreements or our inability to obtain financing on favorable terms may increase our cost of borrowing and limit our activities

RISKS RELATED TO AN INVESTMENT IN OUR SECURITIES

  1. 23Fluctuations in our quarterly or annual results may cause our stock price to decline
  2. 24The market price of our common stock may be volatile, and you may not be able to resell your shares at or above the price you paid

Other Idexx Laboratories 10-Ks

  • FY2024 10-K risk factors
    13 risks

    IDEXX faces manufacturing complexities in biologic diagnostics like rapid assays and water products.

    Filed Feb 21, 2025

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.